Page last updated: 2024-09-04

olmesartan and Overweight

olmesartan has been researched along with Overweight in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Batista, GMS; Campos, MO; Garcia, VP; Gomes, EAC; Mentzinger, J; Nóbrega, ACL; Rocha, HNM; Rocha, NG; Storch, AS; Teixeira, GF1
Davy, BM; Davy, KP; Frisard, MI; Hulver, MW; Marinik, EL; Rivero, JM; Savla, JS1

Trials

1 trial(s) available for olmesartan and Overweight

ArticleYear
Angiotensin II receptor blockade and insulin sensitivity in overweight and obese adults with elevated blood pressure.
    Therapeutic advances in cardiovascular disease, 2013, Volume: 7, Issue:1

    Topics: Angiotensin Receptor Antagonists; Biopsy; Cross-Over Studies; Female; Glucose Tolerance Test; Humans; Hypertension; Imidazoles; Insulin Resistance; Male; Middle Aged; Muscle, Skeletal; Obesity; Overweight; Renin-Angiotensin System; Tetrazoles; Treatment Outcome

2013

Other Studies

1 other study(ies) available for olmesartan and Overweight

ArticleYear
AT1R blocker prevents mental stress induced retrograde blood flow in overweight/obese men.
    Physiological reports, 2023, Volume: 11, Issue:1

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Brachial Artery; Endothelium, Vascular; Humans; Male; Nitrites; Obesity; Overweight; Regional Blood Flow; Stress, Psychological; Vasodilation; Young Adult

2023